Pricing Log in Create free account

Nkarta, Inc. (NKTX) vs Tiziana Life Sciences Ltd (TLSA)

Nkarta, Inc. and Tiziana Life Sciences Ltd are both Biotechnology companies. Nkarta, Inc. and Tiziana Life Sciences Ltd are of similar size ($138.2M and $134.7M). Across the 9 metrics below, Tiziana Life Sciences Ltd leads on 7 and Nkarta, Inc. on 2.

Valuation

Metric NKTX TLSA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.54 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.39 0.04 0.64
EV/Sales n/m n/m 9.21
Earnings yield (87.22%) (49.89%) (33.15%)
Free cash flow yield (70.03%) 0.00% (25.50%)

Profitability

Metric NKTX TLSA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (38.76%) 0.00% (56.36%)
Return on assets (29.86%) 0.00% (48.04%)
Return on invested capital (127.22%) 0.00% 0.00%

Growth

Metric NKTX TLSA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 11.88% (45.45%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NKTX TLSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.98 0.76 4.72
Net debt to EBITDA 2.35 0.19 0.96

Dividend

Metric NKTX TLSA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NKTX TLSA Biotechnology median
Market cap 138.24m 134.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack